A conversation among precision oncology specialists took place at #ESMO24. Drs. Ben Westphalen, Radu Vidra, and David S. Hong shared their insights, clinical experiences, and perspectives as oncologists who research and advocate for the importance of molecular profiling in cancer, while also educating on how to implement biomarkers in clinical oncology practice. In this series we will cover:

The importance of molecular tumour profiling

Comprehensive genomic profiles and biomarker testing are transforming the landscape of oncology. At ESMO 2024, experts discuss how the integration of these technologies into daily clinical practice can make a significant difference in personalized cancer treatment outcomes.

Implementation of biomarker testing in routine clinical practice

On the path to precision oncology, biomarker testing plays a crucial role. From biopsy logistics to mutation interpretation, this approach is transforming how cancer is treated. Additionally, the concept of teamwork through boards focused on evaluating cancer patients is gaining importance. Learn more about the challenges oncologists face and the solutions driving the implementation of precision medicine in daily practice.

Call to action and take home Messages

Discover the steps that specialists recommend to integrate precision oncology into the everyday routine of oncologists.